My ePortfolio Register   

AACR 2017 /
Avelumab for metastatic Merkel cell carcinoma after chemotherapy

1st - 5th Apr 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.04.17
Views: 533
Rating:

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA

Dr Kaufman presents results at AACR 2017 of a trial administering avelumab to patients with advanced Merkel cell carcinoma who had not responded to chemotherapy.

Slides from this presentation are available here, and you can read more about the results here.

Dr Kaufman spoke with ecancer about these results here.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence